AAPL309.18+0.55 (+0.18%) ▲|ABBV254.80-6.25 (-2.39%) ▼|ABT93.61-1.79 (-1.87%) ▼|ACN135.09-2.25 (-1.64%) ▼|ADBE216.03-3.69 (-1.68%) ▼|AMAT615.72+12.68 (+2.10%) ▲|AMD562.04+44.22 (+8.54%) ▲|AMGN361.13-13.02 (-3.48%) ▼|AMT162.48-3.53 (-2.12%) ▼|AMZN242.18-0.49 (-0.20%) ▼|AVGO381.57+21.12 (+5.86%) ▲|AXP352.38+0.42 (+0.12%) ▲|BA229.90+3.41 (+1.51%) ▲|BAC59.59+0.86 (+1.46%) ▲|BKNG183.54-1.02 (-0.55%) ▼|BLK998.89+3.16 (+0.32%) ▲|BMY56.72-1.41 (-2.43%) ▼|BNY149.50+2.88 (+1.96%) ▲|BRK-B505.39-2.39 (-0.47%) ▼|C142.71+2.74 (+1.96%) ▲|CAT985.78+22.25 (+2.31%) ▲|CL92.65-2.48 (-2.61%) ▼|CMCSA23.45-0.35 (-1.45%) ▼|COF206.39+1.27 (+0.62%) ▲|COP104.39-0.34 (-0.32%) ▼|COST943.81-7.87 (-0.83%) ▼|CRM165.45-0.66 (-0.40%) ▼|CSCO114.51+1.82 (+1.62%) ▲|CVS103.44-1.28 (-1.22%) ▼|CVX168.77-0.43 (-0.25%) ▼|DE620.74-0.54 (-0.09%) ▼|DHR191.53-6.40 (-3.23%) ▼|DIS97.55-1.95 (-1.96%) ▼|DUK127.70-1.91 (-1.47%) ▼|EMR141.27+2.22 (+1.60%) ▲|FDX315.80+2.80 (+0.89%) ▲|GD372.78-0.76 (-0.20%) ▼|GE375.58-1.48 (-0.39%) ▼|GEV1,189.67+76.56 (+6.88%) ▲|GILD128.66-2.61 (-1.99%) ▼|GM77.08+1.08 (+1.41%) ▲|GOOG354.41-1.77 (-0.50%) ▼|GOOGL357.63-2.28 (-0.63%) ▼|GS1,044.44+23.44 (+2.30%) ▲|HD348.40-9.50 (-2.65%) ▼|HON227.30-2.56 (-1.11%) ▼|IBM295.43+5.91 (+2.04%) ▲|INTC125.17+4.82 (+4.01%) ▲|INTU271.46-3.89 (-1.41%) ▼|ISRG422.59-3.42 (-0.80%) ▼|JNJ256.86-6.18 (-2.35%) ▼|JPM336.88+3.91 (+1.17%) ▲|KO82.99-1.15 (-1.37%) ▼|LIN536.00-10.64 (-1.95%) ▼|LLY1,189.10-24.81 (-2.04%) ▼|LMT539.40-6.51 (-1.19%) ▼|LOW221.18-6.32 (-2.78%) ▼|LRCX360.97+9.56 (+2.72%) ▲|MA525.81-13.59 (-2.52%) ▼|MCD276.08-4.56 (-1.62%) ▼|MDLZ59.56-1.35 (-2.22%) ▼|MDT82.04-1.16 (-1.39%) ▼|META584.19+1.29 (+0.22%) ▲|MMM158.55-1.89 (-1.18%) ▼|MO71.59-1.12 (-1.54%) ▼|MRK126.34-3.22 (-2.49%) ▼|MS219.27+5.34 (+2.50%) ▲|MSFT385.25-5.24 (-1.34%) ▼|MU994.96+19.40 (+1.99%) ▲|NEE87.39-0.95 (-1.08%) ▼|NFLX76.14-1.51 (-1.94%) ▼|NKE42.74-1.36 (-3.07%) ▼|NOW107.75+1.43 (+1.35%) ▲|NVDA196.53+1.70 (+0.87%) ▲|ORCL142.69+2.42 (+1.73%) ▲|PEP141.97-2.26 (-1.56%) ▼|PFE23.77-0.55 (-2.28%) ▼|PG147.76-3.65 (-2.41%) ▼|PLTR131.42+2.12 (+1.64%) ▲|PM182.20-0.08 (-0.04%) ▼|QCOM186.63+10.38 (+5.89%) ▲|RTX199.39+0.14 (+0.07%) ▲|SBUX101.74-2.54 (-2.43%) ▼|SCHW97.96+0.96 (+0.99%) ▲|SO96.70-1.28 (-1.31%) ▼|SPG223.90-2.16 (-0.96%) ▼|T20.42-0.17 (-0.80%) ▼|TMO511.42-12.02 (-2.30%) ▼|TMUS179.94+2.42 (+1.36%) ▲|TSLA403.09+9.64 (+2.45%) ▲|TXN304.37+11.29 (+3.85%) ▲|UBER73.34-1.09 (-1.46%) ▼|UNH416.47-8.89 (-2.09%) ▼|UNP282.41+0.16 (+0.05%) ▲|UPS110.12-0.54 (-0.49%) ▼|USB62.67+0.94 (+1.52%) ▲|V350.58-11.55 (-3.19%) ▼|VZ42.24-0.32 (-0.75%) ▼|WFC86.55+1.04 (+1.22%) ▲|WMT110.82-1.02 (-0.91%) ▼|XOM136.70-0.39 (-0.28%) ▼|AAPL309.18+0.55 (+0.18%) ▲|ABBV254.80-6.25 (-2.39%) ▼|ABT93.61-1.79 (-1.87%) ▼|ACN135.09-2.25 (-1.64%) ▼|ADBE216.03-3.69 (-1.68%) ▼|AMAT615.72+12.68 (+2.10%) ▲|AMD562.04+44.22 (+8.54%) ▲|AMGN361.13-13.02 (-3.48%) ▼|AMT162.48-3.53 (-2.12%) ▼|AMZN242.18-0.49 (-0.20%) ▼|AVGO381.57+21.12 (+5.86%) ▲|AXP352.38+0.42 (+0.12%) ▲|BA229.90+3.41 (+1.51%) ▲|BAC59.59+0.86 (+1.46%) ▲|BKNG183.54-1.02 (-0.55%) ▼|BLK998.89+3.16 (+0.32%) ▲|BMY56.72-1.41 (-2.43%) ▼|BNY149.50+2.88 (+1.96%) ▲|BRK-B505.39-2.39 (-0.47%) ▼|C142.71+2.74 (+1.96%) ▲|CAT985.78+22.25 (+2.31%) ▲|CL92.65-2.48 (-2.61%) ▼|CMCSA23.45-0.35 (-1.45%) ▼|COF206.39+1.27 (+0.62%) ▲|COP104.39-0.34 (-0.32%) ▼|COST943.81-7.87 (-0.83%) ▼|CRM165.45-0.66 (-0.40%) ▼|CSCO114.51+1.82 (+1.62%) ▲|CVS103.44-1.28 (-1.22%) ▼|CVX168.77-0.43 (-0.25%) ▼|DE620.74-0.54 (-0.09%) ▼|DHR191.53-6.40 (-3.23%) ▼|DIS97.55-1.95 (-1.96%) ▼|DUK127.70-1.91 (-1.47%) ▼|EMR141.27+2.22 (+1.60%) ▲|FDX315.80+2.80 (+0.89%) ▲|GD372.78-0.76 (-0.20%) ▼|GE375.58-1.48 (-0.39%) ▼|GEV1,189.67+76.56 (+6.88%) ▲|GILD128.66-2.61 (-1.99%) ▼|GM77.08+1.08 (+1.41%) ▲|GOOG354.41-1.77 (-0.50%) ▼|GOOGL357.63-2.28 (-0.63%) ▼|GS1,044.44+23.44 (+2.30%) ▲|HD348.40-9.50 (-2.65%) ▼|HON227.30-2.56 (-1.11%) ▼|IBM295.43+5.91 (+2.04%) ▲|INTC125.17+4.82 (+4.01%) ▲|INTU271.46-3.89 (-1.41%) ▼|ISRG422.59-3.42 (-0.80%) ▼|JNJ256.86-6.18 (-2.35%) ▼|JPM336.88+3.91 (+1.17%) ▲|KO82.99-1.15 (-1.37%) ▼|LIN536.00-10.64 (-1.95%) ▼|LLY1,189.10-24.81 (-2.04%) ▼|LMT539.40-6.51 (-1.19%) ▼|LOW221.18-6.32 (-2.78%) ▼|LRCX360.97+9.56 (+2.72%) ▲|MA525.81-13.59 (-2.52%) ▼|MCD276.08-4.56 (-1.62%) ▼|MDLZ59.56-1.35 (-2.22%) ▼|MDT82.04-1.16 (-1.39%) ▼|META584.19+1.29 (+0.22%) ▲|MMM158.55-1.89 (-1.18%) ▼|MO71.59-1.12 (-1.54%) ▼|MRK126.34-3.22 (-2.49%) ▼|MS219.27+5.34 (+2.50%) ▲|MSFT385.25-5.24 (-1.34%) ▼|MU994.96+19.40 (+1.99%) ▲|NEE87.39-0.95 (-1.08%) ▼|NFLX76.14-1.51 (-1.94%) ▼|NKE42.74-1.36 (-3.07%) ▼|NOW107.75+1.43 (+1.35%) ▲|NVDA196.53+1.70 (+0.87%) ▲|ORCL142.69+2.42 (+1.73%) ▲|PEP141.97-2.26 (-1.56%) ▼|PFE23.77-0.55 (-2.28%) ▼|PG147.76-3.65 (-2.41%) ▼|PLTR131.42+2.12 (+1.64%) ▲|PM182.20-0.08 (-0.04%) ▼|QCOM186.63+10.38 (+5.89%) ▲|RTX199.39+0.14 (+0.07%) ▲|SBUX101.74-2.54 (-2.43%) ▼|SCHW97.96+0.96 (+0.99%) ▲|SO96.70-1.28 (-1.31%) ▼|SPG223.90-2.16 (-0.96%) ▼|T20.42-0.17 (-0.80%) ▼|TMO511.42-12.02 (-2.30%) ▼|TMUS179.94+2.42 (+1.36%) ▲|TSLA403.09+9.64 (+2.45%) ▲|TXN304.37+11.29 (+3.85%) ▲|UBER73.34-1.09 (-1.46%) ▼|UNH416.47-8.89 (-2.09%) ▼|UNP282.41+0.16 (+0.05%) ▲|UPS110.12-0.54 (-0.49%) ▼|USB62.67+0.94 (+1.52%) ▲|V350.58-11.55 (-3.19%) ▼|VZ42.24-0.32 (-0.75%) ▼|WFC86.55+1.04 (+1.22%) ▲|WMT110.82-1.02 (-0.91%) ▼|XOM136.70-0.39 (-0.28%) ▼|
21 C
New York
Monday, July 6, 2026

Tag: General

newssourceFORcompanyinformationcontent1releasesmarket

Moehl Millwork Showcases Glenview Doors in 8,000 sq ft Showroom

ANKENY, Iowa, June 20, 2025 /PRNewswire/ -- Moehl Millwork introduces Glenview entry doors designed to enhance the curb appeal and energy efficiency of homes...

GSMA: MWC25 Shanghai showcased tech innovation in robotics, AI and 5G-A from China and Asia to an international audience

MWC25 Shanghai saw strong international participation and attendance, with 45,000 attendees including nearly 4,000 from the C-suite and over 40% representing industries beyond mobile SHANGHAI,...

Information on the voting rights attached to the shares issued by Invalda INVL

Considering that on 17 June 2025 Invalda INVL has entered into agreements to transfer 41,678 treasury shares in order to exercise stock options granted in 2022 to the employees of Invalda INVL and companies in which Invalda INVL holds more than 50% of the shares and that all the transfers have been recorded in the securities accounts, the number of treasury shares of Invalda INVL has decreased to 240,906 units, representing 1.96% of the total number of issued shares of the company, and therefore the number of votes for the calculation of the quorum for the General Meeting of Shareholders of Invalda INVL has changed as of the date of this notice.

Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia

Data Add to Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients Treated with INGREZZA for Tardive Dyskinesia Findings Presented at...

CUPANI METALS CLOSES 1ST TRANCHE OF FINANCING FOR PROCEEDS OF $2.9M

TORONTO, June 20, 2025 /CNW/ - CUPANI METALS CORP. ("CUPANI" or the "Company") (CSE: CUPA) (OTCQB: CUPIF) is pleased to announce that it closed a...

Mazda Canada Inc. Announces Leadership Transition

RICHMOND HILL, ON, June 20, 2025 /CNW/ - Today, Mazda Canada Inc. announces that effective October 1, 2025, David Klan, President and CEO will...

Bilibili Inc. Announces Results of Annual General Meeting

SHANGHAI, June 20, 2025 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that each of the proposed resolutions (the “Proposed Resolutions”) set out in the notice of the annual general meeting dated April 11, 2025 (the “AGM Notice”) has been adopted at its annual general meeting of shareholders held in Shanghai, China today.

PERMIAN BASIN ROYALTY TRUST ANNOUNCES JUNE CASH DISTRIBUTION AND EXCESS COST POSITION ON WADDELL RANCH PROPERTIES

DALLAS, June 20, 2025 /PRNewswire/ -- Argent Trust Company, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian" or the "Trust") today...

New Survey Reveals Missouri Pet Owners Love Adventuring with Their Pets–but a Majority Are Overlooking Key Preventive Veterinary Care

VANCOUVER, Wash., June 20, 2025 /PRNewswire/ -- In celebration of its 70th anniversary, Banfield Pet Hospital, the nation's leading provider of high-quality preventive care,...

METALLIS CLOSES $1,500,000 NON-BROKERED PRIVATE PLACEMENT

VANCOUVER, BC, June 20, 2025 /CNW/ - Metallis Resources Inc. (TSXV: MTS); (OTCQB: MTLFF), (FSE: 0CVM) (the "Company" or "Metallis") announces the closing of its...

Industrial Cleaning Solvents Market worth $1.55 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 20, 2025 /PRNewswire/ -- The report "Industrial Cleaning Solvents Market by Application (General & Medical Device Cleaning, Metal Cleaners, Disinfectants), End-use Industry (Manufacturing...

Industrial Cleaning Solvents Market worth $1.55 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 20, 2025 /PRNewswire/ -- The report "Industrial Cleaning Solvents Market by Application (General & Medical Device Cleaning, Metal Cleaners, Disinfectants), End-use Industry (Manufacturing...

Yiren Digital’s Hexiang Insurance Brokers Launched Innovative Insurance Products for Low-Altitude Economy

BEIJING, June 20, 2025 /PRNewswire/ -- Hexiang Insurance Brokers, the insurance brokerage arm of Yiren Digital, has successfully launched specialized insurance products targeting China's...

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 20 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated extra-pancreatic (epNET) and pancreatic (pNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues. This recommendation is based on results from the CABINET Phase III trial presented at the European Society of Medical Oncology (ESMO) Congress 2024 and published in the New England Journal of Medicine.3,4 A final decision on the approval in the European Union is expected in the coming months.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsGeneral

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers